skip to main content
Idioma:
Refinado por: Lista de Todas as Versões Vaccine remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Control of hepatitis B through routine immunization of infants: the need for flexible schedules and new combination vaccine formulations
Control of hepatitis B through routine immunization of infants: the need for flexible schedules and new combination vaccine formulations
Material Type:
Artigo 		Adicionar ao Meu Espaço

Control of hepatitis B through routine immunization of infants: the need for flexible schedules and new combination vaccine formulations

West, David J. ; Calandra, Gary B. ; Hesley, Teresa M. ; Ioli, Virginia ; Miller, William J.

Vaccine, 1993, Vol.11, p.S21-S27 [Periódico revisado por pares]

Oxford: Elsevier Ltd

Texto completo disponível

Citações Citado por
2
Anti-PRP antibody levels after a primary series of PRP-OMPC and persistence of antibody titres following primary and booster doses
Anti-PRP antibody levels after a primary series of PRP-OMPC and persistence of antibody titres following primary and booster doses
Material Type:
Artigo 		Adicionar ao Meu Espaço

Anti-PRP antibody levels after a primary series of PRP-OMPC and persistence of antibody titres following primary and booster doses

Calandra, G.B. ; Lukacs, L.J. ; Jonas, L.C. ; Santosham, M. ; Ward, J.I. ; Greenberg, D.P. ; Daum, R.S. ; Matthews, H. ; Vella, P.P. ; Ryan, J.L.

Vaccine, 1993, Vol.11, p.S58-S62 [Periódico revisado por pares]

Oxford: Elsevier Ltd

Texto completo disponível

Citações Citado por
3
Inactivated hepatitis A vaccine in childhood: implications for disease control
Inactivated hepatitis A vaccine in childhood: implications for disease control
Material Type:
Artigo 		Adicionar ao Meu Espaço

Inactivated hepatitis A vaccine in childhood: implications for disease control

Nalin, D. ; Brown, L. ; Kuter, B. ; Patterson, C. ; McGuire, B. ; Werzberger, A. ; Santosham, M. ; Block, S. ; Reisinger, K. ; Watson, B. ; Starr, S. ; Pickering, L. ; Lewis, J. ; Miller, W. ; Calandra, G. ; Blatter, M.

Vaccine, 1993, Vol.11, p.S15-S17 [Periódico revisado por pares]

Oxford: Elsevier Ltd

Texto completo disponível

Citações Citado por
4
Safety profile and immunogenicity of an inactivated vaccine derived from an attenuated strain of hepatitis A
Safety profile and immunogenicity of an inactivated vaccine derived from an attenuated strain of hepatitis A
Material Type:
Artigo 		Adicionar ao Meu Espaço

Safety profile and immunogenicity of an inactivated vaccine derived from an attenuated strain of hepatitis A

Ellerbeck, Edward F. ; Lewis, John A. ; Nalin, David ; Gershman, Kenneth ; Miller, William J. ; Armstrong, Marcy E. ; Davide, Joseph P. ; Rhoad, Audrey E. ; McGuire, Brenda ; Calandra, Gary ; Provost, Philip J. ; Midthun, Karen

Vaccine, 1992, Vol.10 (10), p.668-672 [Periódico revisado por pares]

OXFORD: Elsevier Ltd

Texto completo disponível

Citações Citado por
5
Comparative safety and immunogenicity of yeast recombinant hepatitis B vaccines containing S and pre-S2 + S antigens
Comparative safety and immunogenicity of yeast recombinant hepatitis B vaccines containing S and pre-S2 + S antigens
Material Type:
Artigo 		Adicionar ao Meu Espaço

Comparative safety and immunogenicity of yeast recombinant hepatitis B vaccines containing S and pre-S2 + S antigens

Miskovsky, Emil ; Gershman, Kenneth ; Clements, Mary Lou ; Cupps, Thomas ; Calandra, G. ; Hesley, Teresa ; Ioli, Virginia ; Ellis, Ronald ; Kniskern, Peter ; Miller, William ; Gerety, R. ; West, David

Vaccine, 1991-05, Vol.9 (5), p.346-350 [Periódico revisado por pares]

Oxford: Elsevier Ltd

Texto completo disponível

Citações Citado por

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.